Camilla Soenderby

Camilla Soenderby

Director/Board Member at BB BIOTECH AG

Net worth: - $ as of 30/06/2026

54 year
Health Technology
Distribution Services
Finance

Profile

Ms. Camilla Soenderby is an Independent Director at Inventiva SA and an Independent Director at Abivax SA. She is on the Board of Directors at Inventiva SA, Abivax SA, BB Biotech AG, F2G Ltd. and Affibody Medical AB. Ms. Soenderby was previously employed as a Head-Product Strategy Officer by Takeda Pharmaceutical Co., Ltd., a Head-Global Product Strategy by Shire France SAS, a General Manager by AbbVie SAS (France), and a General Manager by Schering-Plough Ltd. (Taiwan).
She received her undergraduate degree from the University of Copenhagen.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
28/02/2026 0 ( -.--% ) - $ 30/06/2026

Camilla Soenderby active positions

CompaniesPositionStart
BB BIOTECH AG Director/Board Member 21/03/2024
ABIVAX Director/Board Member 02/04/2024
INVENTIVA Director/Board Member 30/06/2026
Director/Board Member 15/09/2021
Director/Board Member -

Former positions of Camilla Soenderby

CompaniesPositionEnd
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01/01/2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Camilla Soenderby's experience

Training of Camilla Soenderby

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

29

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Distribution Services

  1. Stock Market
  2. Insiders
  3. Camilla Soenderby